Targeting Launch of Platform by Year's End, GnuBio Bets on Gene Panels, Replacing Sanger Assays
February 28, 2012
Targeting Launch of Platform by Year's End, GnuBio Bets on Gene Panels, Replacing Sanger Assays
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GnuBio Licenses Microfluidics, Emulsion Methods for DNA Sequencing from Harvard
August 31, 2010 / In Sequence - Montreal Heart Institute Developing GnuBio Sequencing Panel for Sudden Cardiac Death Test
February 1, 2012 / Pharmacogenomics Reporter - GnuBio Targets 1K-Base Reads for Commercial Launch of $50K Sequencer
October 4, 2011 / In Sequence - GnuBio to Ship Early Version of Sequencer to Montreal Heart Institute
June 14, 2011 / In Sequence - GnuBio Claims Proof of Principle for Sequencing; Plans to Ship Early Commercial Systems by Year-End
April 12, 2011 / In Sequence